Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
EP300 mutation
Description:
A genetic alteration in EP300, the gene encoding a transcriptional coactivator involved in chromatin regulation and gene expression.
Related topics:
Lymphoma Diagnosis and Treatment (19%),
Congenital limb and hand anomalies (10%)
OpenAlex ID:
keywords/ep300-mutation
CREBBP mutations in relapsed acute lymphoblastic leukaemia
2011
·
Charles G. Mullighan
, Jinghui Zhang
, et al.
·
Nature
·
677
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
2021
·
Yao-Hui Huang
, Kun Cai
, et al.
·
Signal Transduction and Targeted Therapy
·
253
PDF
Claudin-low bladder tumors are immune infiltrated and actively immune suppressed
2016
·
Jordan Kardos
, Shengjie Chai
, et al.
·
JCI Insight
·
215
Phenotype and genotype in 52 patients with Rubinstein–Taybi syndrome caused by EP300 mutations
2016
·
Patricia Fergelot
, Martine Van Belzen
, et al.
·
American Journal of Medical Genetics Part A
·
150
PDF
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma
2019
·
Anja Mottok
, Stacy S. Hung
, et al.
·
Blood
·
138
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies
2018
·
Urvi A. Shah
, Elaine Y. Chung
, et al.
·
Blood
·
96
PDF
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort
2017
·
Darius Juskevicius
, David Jucker
, et al.
·
Journal of Hematology & Oncology
·
92
PDF
Rubinstein–Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum
2016
·
Mark J. Hamilton
, Ruth Newbury-Ecob
, et al.
·
Clinical Dysmorphology
·
79
Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein–Taybi syndrome
2009
·
Oliver Bartsch
, Janette Labonté
, et al.
·
American Journal of Medical Genetics Part A
·
75
Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal Cancer
2022
·
Andreana N. Holowatyj
, Wanqing Wen
, et al.
·
Cancer Discovery
·
73
PDF
Ultra-Rare Syndromes: The Example of Rubinstein–Taybi Syndrome
2015
·
Silvia Spena
, Donatella Milani
, et al.
·
Journal of Pediatric Genetics
·
73
M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line rituximab chemo‐free therapy
2019
·
Sandra Lockmer
, Weicheng Ren
, et al.
·
British Journal of Haematology
·
69
CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas
2020
·
Kylee J. Veazey
, Donghang Cheng
, et al.
·
Leukemia
·
61
Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma
2020
·
Mu-Chen Zhang
, Ying Fang
, et al.
·
Clinical Epigenetics
·
58
PDF
Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features
2021
·
Xiaolong Alan Zhou
, Jingyi Yang
, et al.
·
Blood Advances
·
56
PDF
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients
2024
·
Mathieu Simonin
, Loïc Vasseur
, et al.
·
Blood
·
55
PDF
The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma
2024
·
Guozhong Jiang
, Zhizhong Wang
, et al.
·
Nature Communications
·
53
PDF
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum
2018
·
María López
, Alberto García-Oguiza
, et al.
·
BMC Medical Genetics
·
50
PDF
Genetic dysregulation of EP300 in cancers in light of cancer epigenome control – targeting of p300-proficient and -deficient cancers
2024
·
Karolina Gronkowska
, Agnieszka Robaszkiewicz
·
Molecular Therapy Oncology
·
43
PDF
CREBBP and EP 300 mutational spectrum and clinical presentations in a cohort of S wedish patients with R ubinstein– T aybi syndrome
2015
·
Josephine Wincent
, Aron Luthman
, et al.
·
Molecular Genetics & Genomic Medicine
·
35
PDF
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies
2022
·
Inna Serganova
, Sanjukta Chakraborty
, et al.
·
Frontiers in Cell and Developmental Biology
·
31
PDF
Two adults with Rubinstein–Taybi syndrome with mild mental retardation, glaucoma, normal growth and skull circumference, and camptodactyly of third fingers
2009
·
Dagmar Wieczorek
, Oliver Bartsch
, et al.
·
American Journal of Medical Genetics Part A
·
20
Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait
2019
·
Xiao-tong Wang
, Ru Fang
, et al.
·
Pathology - Research and Practice
·
18
Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial
2024
·
Ming-Ci Cai
, Shu Cheng
, et al.
·
The Lancet Regional Health - Western Pacific
·
17
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399
2023
·
Ryan D Gentzler
, Liza C Villaruz
, et al.
·
The Oncologist
·
16
PDF
Show more works
View as search
Works count:
107
Citation count:
2,740
Year
Topic
Type